ClinicalTrials.gg
Not yet recruitingNCT07768527Updated Aug 17, 2026

Virtual Reality and Simulation-Based Breastfeeding Training

An interventional study of Virtual Reality Group and Simulation Group in Postpartum Women, Lactation Power and Lactation Success, sponsored by Cukurova University. Not yet recruiting. Open to female participants aged 18 Years to 49 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-17.

Sponsored by Cukurova University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
159
Allocation
Randomized
Ages
18 Years to 49 Years
Sex
Female
01

Study summary

The aim of this study is to determine the effect of virtual reality and simulation-based breastfeeding education given to mothers experiencing breastfeeding problems in the postpartum period on breastfeeding potency, breastfeeding success, and breastfeeding continuation. The research is a randomized controlled experimental study.

Read the detailed description

The study population will consist of postpartum women who apply to the Lactation Counseling Clinic of the Obstetrics and Gynecology and Pediatric Hospital. The sample will consist of women who voluntarily participate in the study. Data will be collected through face-to-face interviews. Data will be collected by completing the "Personal Information Form", the "Mother's Breastfeeding Ability Scale" and the "Bristol Breastfeeding Assessment Scale".

02

Conditions studied

  • Postpartum Women
  • Lactation Power
  • Lactation Success
  • Maintenance of Breastfeeding

Browse trials for

03

In context

Breast Feeding

1,081 studies on the registry are indexed under Breast Feeding; 217 are open to participants now.

This study's planned enrollment of 159 is above the median of 100 across 844 interventional studies indexed under Breast Feeding.

Browse Breast Feeding studies →

Lead sponsor

Cukurova University is the lead sponsor of 259 studies on the registry; 50 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 49 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Primiparous
  • Infant in the neonatal period
  • Over 18 years of age
  • Term delivery
  • Healthy baby and individual
  • No communication barriers
  • Willing to participate in the study
  • Able to read and write Turkish

Exclusion criteria

Exclusion Criteria:

  • Multiparous
  • Infant not in the neonatal period
  • Under 18 years of age
  • Premature delivery
  • Unhealthy baby and individual
  • No communication barriers
  • Unwilling to participate in the study
  • Unable to read and write Turkish
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
159 participants (estimated)

Study arms

  • Experimental
    Virtual Reality Group

    Mothers in this group will receive breastfeeding training using virtual reality glasses.

    Behavioral: Simulation Group · Behavioral: control group

  • Experimental
    Simulation Group

    Mothers in this group will receive breastfeeding training using wearable nursing covers and newborn baby mannequins.

    Behavioral: Virtual Reality Group · Behavioral: control group

  • Active comparator
    Control Group

    Mothers in this group will receive breastfeeding training as part of routine hospital protocol.

    Behavioral: Virtual Reality Group · Behavioral: Simulation Group

Interventions

  • BehavioralVirtual Reality Group

    Mothers in this group will receive breastfeeding training using virtual reality glasses.

  • BehavioralSimulation Group

    Mothers in this group will receive breastfeeding training using wearable nursing covers and newborn baby mannequins.

  • Behavioralcontrol group

    Mothers in this group will receive breastfeeding training as part of routine hospital protocol.

06

What researchers measure

Primary outcomes

  1. Mother's Breastfeeding Strength Scale

    This is a 37-item, 5-point Likert-type scale developed to assess mothers' breastfeeding strength level. Scale items are scored from "1 = Strongly disagree" to "5 = Strongly agree." There are no reverse-scored items. The total score ranges from 37 to 185. A higher total score indicates a higher level of breastfeeding strength in the mother. Subscale scores are calculated by summing the items in the relevant subscale. Higher scores indicate a more positive situation in terms of breastfeeding knowledge and skills, perceived competence, beliefs about breastfeeding, coping with breastfeeding problems, providing family support, and breastfeeding self-efficacy.

    Time frame: up to 12 months

Secondary outcomes

  1. Bristol Breastfeeding Assessment Scale

    Developed by Jenny Ingram in 2014 and adapted into Turkish by Dolgun et al. in 2017, the scale is designed to assess common breastfeeding problems and adequacy in the postpartum period. The mother is observed by a midwife/nurse during breastfeeding, and the form is completed based on the criteria, evaluating both mother and baby. The application time is 5-10 minutes. While the original version of the scale had a Cronbach's Alpha of 0.68, the Turkish adaptation yielded 0.77. In our study, the reliability coefficient was determined to be 0.87. The measurement tool is a Likert-type scale consisting of 4 items: "positioning," "holding," "sucking," and "swallowing."

    Time frame: up to 12 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for Mar 2027, 6 months later.

Of 502 non-industry interventional studies with no phase under Breast Feeding, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 6 months is below that.

Counting every sponsor, half of 510 studies reached it within 12 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 12, 2026
First posted
Aug 17, 2026
StartEst.
Sep 1, 2026
Primary completionEst.
Mar 1, 2027
CompletionEst.
Apr 1, 2027
Last update
Aug 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07768527
Responsible party
Elif DAĞLI (Associate Professor, Cukurova University) — Principal investigator
First posted
Aug 17, 2026
Start date
Sep 1, 2026 (estimated)
Primary completion
Mar 1, 2027 (estimated)
Completion
Apr 1, 2027 (estimated)
Last update
Aug 17, 2026

Study contacts

Elif DAĞLI, Associate Professor
Contact
elifarik90@gmail.com
+903223386560 ext. 146

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion